The Indian Pharmaceutical Industry (IPI) is globally the 3rd largest in terms of volume and 13th largest in terms of value. The industry is expected to growth at a robust CAGR during FY2012-17 given the huge export potential coupled with steady growth in the domestic formulation market. Growth in the domestic pharma market will be driven by increase in the penetration of medical facilities, rising prevalence of chronic diseases and rising per capita income. The growth in the US market will be led by increasing generic penetration and healthy ANDA pipeline of Indian pharma players. In the long term, growth in the exports market will be sustained by emerging markets such as Russia, Brazil, and South Africa etc. along with the enhanced focus on the niche and complex product segments. The report on 'Indian Pharmaceutical Industry' gives valuable insight on basics of the industry, domestic demand and growth drivers, exports and imports statistics, regulatory landscape and a performance analysis of key players. The report also provides CARE Research's Outlook on the domestic and exports market for the next 5 years.
To receive CARE Research publications and alerts.